摘要
患者女,71岁。全身出现红斑、丘疹伴瘙痒2个月。患者2个月前口服"甲磺酸伊马替尼片"等药物,服药5天后躯干、四肢近端出现红斑及丘疹,逐渐泛发全身,瘙痒剧烈,既往2年前曾口服"甲磺酸伊马替尼片"出现类似皮疹,经治疗痊愈。左下肢红斑组织病理示:表皮角化过度伴角化不全,基底层细胞液化变性,真皮带状致密炎症浸润,主要为淋巴细胞,少量嗜酸性粒细胞。诊断:扁平苔藓样药疹。给予抗过敏、抗炎、止痒等治疗后好转。
A 71-year-old female patient presented with erythemas and papules all over the body for two months,which due to the use of imatinib mesylate. Five days later she developed erythemas and plaques on the trunk and limbs,and the skin lesion progressed to the whole body gradually. She had presented similar lesion because of using imatinib mesylate two years ago. Skin biopsy was performed on his left lower leg. Specimen showed epidermal hyperkeratosis with parakeratosis,liquefaction degeneration of the basal cell layer,lichenoid lymphocytic infiltration and fewer numerous eosinophils infiltration on the upper dermis and deep dermis. It was diagnosed as lichenoid drug eruption according clinical manifestations and auxiliary examination. Anti-allergy,anti-inflammatory and anti-itching were given as the treatment.
引文
[1]Brauer J,Votava HJ,Meehan S,et al.Lichenoid drug eruption[J].Dermatol Online J,2009,15(8):13.
[2]程燕,陈晓玫,汪盛.扁平苔藓样药疹1例[J].中国皮肤性病学杂志,2011,25(7):560-561.
[3]Heidary N,Naik H,Burgin S.Chemotherapeutic agents and the skin:an update[J].J Am Acad Dermatol,2008,58(4):545-570.
[4]Brouard M,Saurat JH.Cutaneous reactions to STI571[J].N Engl J Med,2001,345(8):618-619.
[5]杨欢,蒋洁瑶,苏忠兰,等.甲磺酸伊马替尼诱导的皮肤反应与治疗对策[J].国际皮肤性病学杂志,2013,39(5):318-320.
[6]Kagimoto Y,Mizuashi M,Kikuchi K,et al.Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate[J].International Journal of Dermatology,2014,53(3):e161-e162.
[7]Kuraishi N,Nagai Y,Hasegawa M.Lichenoid Drug Eruption with Palmoplantar Hyperkeratosis due to Imatinib Mesylate:A Case Report and a Review of the Literature[J].Acta Derm Venereol,2010,90(1):73-76.
[8]Roux C,Boisseau-Garsaud AM,Saint-Cyr I,et al.Lichenoid cutaneous reaction to imatinib[J].Ann Dermatol Venereol,2004,131(6-7 Pt1):571-573.
[9]Dalmau J,Peramiquel L,Puig L,et al.Imatinib-associated lichenoid eruption:acitretin treatmentallows maintained antineoplastic effect[J].Br J Dermatol,2006,154(6):1213-1216.